TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578,477 | -8.6% | 205,814 | -1.1% | 0.00% | – |
| Q2 2023 | $632,630 | -17.5% | 208,102 | -49.0% | 0.00% | – |
| Q1 2023 | $767,246 | +204498.9% | 408,110 | +10.9% | 0.00% | – |
| Q4 2022 | $375 | -100.0% | 367,920 | -1.5% | 0.00% | – |
| Q3 2022 | $982,000 | -21.2% | 373,447 | +35.1% | 0.00% | – |
| Q2 2022 | $1,246,000 | -53.2% | 276,349 | +2.0% | 0.00% | – |
| Q1 2022 | $2,665,000 | -29.1% | 270,864 | +10.2% | 0.00% | – |
| Q4 2021 | $3,758,000 | +61.8% | 245,823 | +43.5% | 0.00% | – |
| Q3 2021 | $2,323,000 | +2.7% | 171,335 | +11.2% | 0.00% | – |
| Q2 2021 | $2,263,000 | – | 154,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |